Two Hot Stocks on the Run: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Knowles Corporation (NYSE:KN)

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)

The shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) started off the last trading session with the price of $8.32 while closing the day with the price of $8.44. The shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Rise 1.69% with the Gain of 0.12 points.

The shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) traded with the day volume of 1.65 Million shares whereas its average trading volume is 1.44 Million.

While analyzing the past performance of the stock we can see that the shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Gain 4.2% in the last week while rising 47.55% in the last month. Past quarter performance shows the green light with 37.91%. The semi-annual and annual performance shows 35.69% and -26.22% respectively.

Some critical values of the shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) to be discussed here are: the beta which shows the value at 2.58 while Average True Range of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) demonstrate the value at 0.39. The weekly and monthly volatility of the shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) are indicated at 4.60% and 5.38%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 76.53.

While studying the financial position of the shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), we can see that the Market capitalization of the company is at 594.49 Million. The shares outstanding for the company is 70.44 Million and the shares float stands at 69.85 Million. The income of the company stand at -54700000 while the sales stand at 11.7 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.78, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 50.81, the Return on Asset ROA stood at -0.313 and the Return on Equity ROE depicted at -0.71 while Return on Investment ROI is at -0.446.


Knowles Corporation (NYSE:KN)

Knowles Corporation (NYSE:KN) started its previous trading session at $13.79 and closed at $13.93 showing a Rise of 1.02 Percent.

The Company traded with an average Volume of 936.6 Million whereas, its Day Volume stood at 1.65 Million.

Looking at the performance of the stock, Knowles Corporation (NYSE:KN) Loss -4.13% in the last week in its shares price and -1.28% in the last month. Quarterly performance shows a red of -5.17 Percent while Semi-Annual and Annual performances shows a -7.44 and -26.65 percent respectively.

Beta for Knowles Corporation (NYSE:KN) stands at 0.78 while the ATR (average true range) is at 0.43. The Stock’s Weekly and Monthly Volatility is 2.81% and 2.57% respectively showing a RSI value of 34.65.

While studying the financial position of the shares of Knowles Corporation (NYSE:KN), we can see that the Market capitalization of the company is at 1.24 Billion. The shares outstanding for the company is 88.97 Million and the shares float stands at 88.34 Million.

The Company generated an income of 24.5 Million and the sales of 744.2 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $0.25 a share. P/E (price to earnings) and P/S (price to sales) values are 56.4 and 1.67 respectively.

The Return on Assets stands at 0.044, ROE shows a value of 0.065 and ROI for Knowles Corporation (NYSE:KN) is 0.034 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment